Navigation Links
Envera Increases Scientific Staff
Date:2/14/2013

West Chester, PA (PRWEB) February 14, 2013

Envera announced today the addition of Jeffrey Holt and Nantiya Abraham to the Research and Development staff. Dr. Holt enters the company as a Research Scientist with Mrs. Abraham serving as a Research Technician.

Mike Matheny, President and Owner of Envera stated, “The continued growth of our business, and Envera’s focus on research and development, has prompted the addition of laboratory personnel. We are pleased to have Dr. Holt and Mrs. Abraham join our team and I look forward to their assistance with several laboratory projects”, added Matheny. “With almost 20 years of combined laboratory experience I am sure they will have a positive impact on our future”, concluded Matheny.

Dr. Holt holds a Bachelor’s Degree in Microbiology from Ohio University, a Masters of Biotechnology from the University of Pennsylvania, and a Ph.D. in Biological Sciences from Drexel University. Jeff’s Ph.D thesis focused on the Isolation and Characterization of Novel Mutants of Campylobacter jejuni. Jeffrey brings Envera a diverse background in molecular biology, bacteriophage expertise, and an extensive background in animal pathogen infection and modeling.

Mrs. Abraham earned a Bachelor’s of Science Degree in Microbiology from Naresuan University. Nantiya spent 4 years as a Quality Control Analyst for Mead Johnson Nutrition Ltd, a manufacturer of infant formula and other milk products. While in this position Nantiya performed a variety of microbiological tests to insure the safety and quality of the Mead Johnson Nutrition product line in an ISO/IEC 17025 and GMP/GLP environment.

“I am excited to join Envera where I can apply my academic background to help solve real world issues”, stated Dr. Holt. “Envera’s focus on the development of environmentally friendly products is especially appealing to me”, finished Jeff. “I am looking forward to being part of a team focused on the use of beneficial microorganisms to replace harsh chemicals”, added Mrs. Abraham.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, waste water, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at mmatheny(at)envera(dot)com or phone 484-593-4002 for more information.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10425366.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. iDiverse Discovers Yeast Gene that Increases Fuel Ethanol Production Yield
2. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
3. Voltage increases up to 25 percent observed in closely packed nanowires at Sandia Labs
4. Transonic sponsors Flow Measurement workshop at 9th Annual Scientific meeting of the Society of Diagnostic and Interventional Nephrology
5. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
6. Salimetrics to Present Workshop on the Integration of Salivary Analytes into Scientific Studies at the Society for Research in Child Development (SRCD) Preconference
7. Prizmatix Introduces Ultra High Power LED with Over 4 Watts of Collimated White Light for Scientific and Industrial Applications
8. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
9. Source Scientific LLC is 100% Acquired by BIT Analytical Instruments
10. MakeSigns.com Announces New Tri-Fold Scientific Poster Service
11. APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market Research Report at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... Scientists at the ... options being tried for mesothelioma may be hampering the research that could lead to ... Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... Food and Drug Administration (FDA) has granted the company’s orphan drug designation request ... second orphan drug designation granted by the FDA. , Spinocerebellar ataxia is ...
(Date:5/24/2016)... ... ... Last week, Callan Capital, an integrated wealth management firm specializing in asset ... Diego Life Science event at the Estancia La Jolla Resort and Spa. , Over ... Dr. Rich Heyman, former CEO of Aragon and Seragon, and Faheem Hasnain, former CEO ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® ... Farming in 2017 and Beyond. The paper outlines the key trends that are ... industry. , “We’ve witnessed a lot of highs and lows as the precision ...
Breaking Biology Technology:
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):